Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
24.08
-0.59 (-2.37%)
Nov 16, 2026, 4:00 PM EST - Market closed
Fulgent Genetics Revenue
Fulgent Genetics had revenue of $90.41M in the quarter ending September 30, 2026, with 7.54% growth. This brings the company's total for the last twelve months to $330.28M, up 4.67% year-over-year. In the year 2025, Fulgent Genetics had annual revenue of $322.67M with 13.83% growth. That makes Fulgent Genetics the 13,850th largest company in the world by revenue and 2,549th in the United States.
Revenue (ttm)
$330.28M
Revenue Growth
+4.67%
P/S Ratio
2.04
Revenue / Employee
$251,160
Employees
1,315
Market Cap
672.63M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Fulgent Genetics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 322.67M | 39.20M | 13.83% |
| Dec 31, 2024 | 283.47M | -5.74M | -1.99% |
| Dec 31, 2023 | 289.21M | -329.76M | -53.27% |
| Dec 31, 2022 | 618.97M | -373.62M | -37.64% |
| Dec 31, 2021 | 992.58M | 570.87M | 135.37% |
| Dec 31, 2020 | 421.71M | 389.18M | 1,196.46% |
| Dec 31, 2019 | 32.53M | 11.18M | 52.35% |
| Dec 31, 2018 | 21.35M | 2.62M | 13.99% |
| Dec 31, 2017 | 18.73M | 454.00K | 2.48% |
| Dec 31, 2016 | 18.28M | 8.70M | 90.85% |
| Dec 31, 2015 | 9.58M | 8.30M | 649.30% |
| Dec 31, 2014 | 1.28M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 803.60M |
| NeoGenomics | 787.75M |
| OPKO Health | 654.10M |
| Veracyte | 581.78M |
| CareDx | 497.40M |
| GeneDx Holdings | 460.78M |
| Castle Biosciences | 377.13M |
| Freenome | 217.86M |
FLGT News
- 6 days ago - Fulgent Genetics price target raised to $25 from $19 at Piper Sandler - TheFly
- 11 days ago - Fulgent Genetics reports Q3 EPS (48c) vs. (21c) last year - TheFly
- 11 days ago - Fulgent Genetics sees FY26 EPS ($1.75) to ($1.65), consensus ($2.27) - TheFly
- 11 days ago - Fulgent Genetics Earnings Call Transcript: Q3 2026 - Transcripts
- 11 days ago - Fulgent Genetics Earnings release: Q3 2026 - Filings
- 11 days ago - Fulgent Genetics Quarterly report: Q3 2026 - Filings
- 11 days ago - Fulgent Genetics Slides: Q3 2026 - Filings
- 11 days ago - Fulgent Reports Third Quarter 2026 Financial Results - Business Wire